PepGen Inc. Banner Image

PepGen Inc.

  • Ticker PEPG
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
PepGen Inc. Logo Image
  • 51-200 Employees
  • Based in Boston, Massachusetts
PepGen Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen’s Enhanced Delivery Oligonucleotide, or EDO, platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake andMore activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, they are generating a pipeline of oligonucleotide therapeutic candidates that are designed to target the root cause of serious diseases.
PepGen Inc.

Most Recent Annual Report

PepGen Inc.
MOST RECENT 2022 Annual Report and Form 10K
PepGen Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!